Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
Links shared publicly online about this topic.
- 1,723total visits
Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
fda.gov —
View full resource at fda.gov
Tags: Diabetes Type 2 Medication, Januvia
Most Recently Shared on September 26, 2009 at 8:50 pm By:
Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis WARNING: http://tinyurl.com/ydkhmqt
Also Shared By:
FDA links Januvia to pancreatitis - FiercePharma
fiercepharma.com — “Concerned by post-marketing cases of pancreatitis, FDA is adding the reports to labeling on Merck's (MRK) diabetes drug Januvia (sitagliptin) and a combo form of the drug, Janumet. The agency is... Read more...” View full resource at fiercepharma.com
Most Recently Shared on September 30, 2009 at 6:48 pm By:
RT @safety_alertss: #Drug #PtSafety #FDA links Januvia to pancreatitis Merck's #diabetes medication, new use #labeling. http://ow.ly/rLrk
Safety profiles of JANUVIA and JANUMET drugs established through clinical development program
news-medical.net — “Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.” View full resource at news-medical.net
Most Recently Shared on September 28, 2009 at 7:19 pm By:
Stroke News: Safety profiles of JANUVIA and JANUMET drugs established through clinical development .. http://twurl.nl/yscc41
Advertisement
eyeonfda
@eyeonfda
MedWatch Alert on Januvia - http://bit.ly/qkALL
1 year ago...